Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
M. Kathleen Behrens currently holds 214,357 shares of Sarepta Therapeutics, Inc. (SRPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, M. Kathleen Behrens has been a net buyer of SRPT stock. They have purchased $12.7M and sold $1.7M worth of shares.
M. Kathleen Behrens's most recent insider trade was on Jun 4, 2026, when they sold 16,875 shares at $0.00 per share.
M. Kathleen Behrens serves as Executive at Sarepta Therapeutics, Inc. (SRPT). They have executed 98 insider transactions totaling $14.5M over their tenure at the company.
M. Kathleen Behrens holds the position of Executive at Sarepta Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
M. Kathleen Behrens has shown a buying trading pattern, with $12.7M in total purchases and $1.7M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by M. Kathleen Behrens was on Dec 11, 2020, when they purchased $2.0M worth of IGMS shares. This transaction involved 22,222 shares at $90.00 per share.
M. Kathleen Behrens currently owns 214,357 shares of Sarepta Therapeutics, Inc. (SRPT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of M. Kathleen Behrens's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. M. Kathleen Behrens has 98 Form 4 filings on record as an insider at Sarepta Therapeutics, Inc..
Set alerts for M. Kathleen Behrens and 40,000+ other insiders.